What is Infinite Biomedical Technologies?
Infinite Biomedical Technologies operates as a specialized translational research and medical device enterprise, dedicated to the seamless transition of complex technologies from bench to bedside. The organization is primarily focused on the development of advanced upper limb prosthetic devices and sophisticated control systems. By engineering high-fidelity interfaces between human physiology and mechanical prosthetics, the company aims to restore functional autonomy to amputees. Their market position is defined by a rigorous commitment to biomedical engineering excellence and a deep understanding of the clinical requirements necessary to improve patient outcomes in the prosthetic space.
How much funding has Infinite Biomedical Technologies raised?
Infinite Biomedical Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Infinite Biomedical Technologies
PPP
Public-Private Partnership
What's next for Infinite Biomedical Technologies?
With the recent influx of capital, Infinite Biomedical Technologies is poised to scale its late-stage development efforts, focusing on the commercialization and clinical validation of its proprietary control systems. The strategic roadmap likely involves expanding manufacturing capabilities and deepening regulatory engagement to ensure widespread adoption of their prosthetic solutions. As the company transitions from a research-heavy entity to a commercial-stage powerhouse, the focus will shift toward optimizing supply chain logistics and establishing long-term partnerships with healthcare providers. This phase of growth is critical for cementing their status as a dominant player in the assistive technology market, ultimately driving both clinical impact and long-term shareholder value.
See full Infinite Biomedical Technologies company page
